HomeCompareLBRG vs JNJ

LBRG vs JNJ: Dividend Comparison 2026

LBRG yields 14388.49% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBRG wins by $2005708871003771392.00M in total portfolio value
10 years
LBRG
LBRG
● Live price
14388.49%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2005708871003771392.00M
Annual income
$1,978,657,258,734,465,300,000,000.00
Full LBRG calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LBRG vs JNJ

📍 LBRG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBRGJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBRG + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBRG pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBRG
Annual income on $10K today (after 15% tax)
$1,223,021.58/yr
After 10yr DRIP, annual income (after tax)
$1,681,858,669,924,295,300,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LBRG beats the other by $1,681,858,669,924,295,300,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBRG + JNJ for your $10,000?

LBRG: 50%JNJ: 50%
100% JNJ50/50100% LBRG
Portfolio after 10yr
$1002854435501885696.00M
Annual income
$989,328,629,367,232,700,000,000.00/yr
Blended yield
98.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LBRG
No analyst data
Altman Z
4.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBRG buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBRGJNJ
Forward yield14388.49%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$2005708871003771392.00M$30.3K
Annual income after 10y$1,978,657,258,734,465,300,000,000.00$4,689.40
Total dividends collected$2003918040391760896.00M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LBRG vs JNJ ($10,000, DRIP)

YearLBRG PortfolioLBRG Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,449,549$1,438,848.92$10,592$272.30+$1.44MLBRG
2$196,474,559$194,923,542.10$11,289$357.73+$196.46MLBRG
3$24,902,096,749$24,691,868,970.40$12,123$472.89+$24902.08MLBRG
4$2,951,469,517,816$2,924,824,274,294.62$13,141$629.86+$2951469.50MLBRG
5$327,138,211,038,176$323,980,138,654,113.20$14,408$846.81+$327138211.02MLBRG
6$33,910,472,885,988,016$33,560,435,000,177,170.00$16,021$1,151.60+$33910472885.97MLBRG
7$3,287,504,337,429,561,000$3,251,220,131,441,553,400.00$18,122$1,588.22+$3287504337429.54MLBRG
8$298,092,086,846,622,500,000$294,574,457,205,572,900,000.00$20,930$2,228.20+$298092086846622.56MLBRG
9$25,281,880,625,519,608,000,000$24,962,922,092,593,716,000,000.00$24,792$3,191.91+$25281880625519608.00MLBRG
10$2,005,708,871,003,771,300,000,000$1,978,657,258,734,465,300,000,000.00$30,274$4,689.40+$2005708871003771392.00MLBRG

LBRG vs JNJ: Complete Analysis 2026

LBRGStock

Ladybug Resource Group, Inc. designs the message or marketing theme included on Internet Websites, primarily focusing on the Websites of the funeral industry in the Seattle, Washington area. The company is also developing Solar Tracer, a solar collector that would use concentrating solar power technology to capture energy from the sun and transfer it in the form of heat to run steam turbine generators. In addition, it offers health supplements for men and women that help with issues, such as sleeplessness, headaches, aches and pains, mood improvement, energy, calm support, and appetite control; athletic supplements to enhance and sustain athletic performance; and nutritional supplement products. The company intends to sell its health products and formulas through wholesale channels; or license products to other manufacturers or multi-level marketing organizations. Ladybug Resource Group was founded in 2007 and is based in Kirkland, Washington.

Full LBRG Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LBRG vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBRG vs SCHDLBRG vs JEPILBRG vs OLBRG vs KOLBRG vs MAINLBRG vs ABBVLBRG vs MRKLBRG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.